- Report
- March 2024
- 135 Pages
Global
From €3766EUR$3,899USD£3,221GBP
- Report
- March 2024
- 138 Pages
Global
From €3766EUR$3,899USD£3,221GBP
- Report
- March 2024
- 135 Pages
Global
From €3766EUR$3,899USD£3,221GBP
- Report
- May 2024
- 198 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- May 2024
- 171 Pages
Global
From €5265EUR$5,450USD£4,502GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 200 Pages
Global
From €3864EUR$4,000USD£3,304GBP
- Report
- December 2023
- 200 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- November 2023
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- April 2024
- 137 Pages
Global
From €3766EUR$3,899USD£3,221GBP
- Report
- March 2024
- 147 Pages
Global
From €3766EUR$3,899USD£3,221GBP
- Report
- March 2024
- 144 Pages
Global
From €3766EUR$3,899USD£3,221GBP
- Report
- January 2024
- 145 Pages
Global
From €3766EUR$3,899USD£3,221GBP
- Report
- November 2023
- 142 Pages
Global
From €2414EUR$2,499USD£2,064GBP
- Report
- June 2023
- 140 Pages
Global
From €2414EUR$2,499USD£2,064GBP
- Report
- October 2023
- 189 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- October 2023
- 184 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- June 2023
- 116 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- February 2024
- 179 Pages
Global
From €4588EUR$4,750USD£3,923GBP
The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more